Biomineralization scaffold

A biomineralization scaffold is a structural framework, typically composed of an organic extracellular matrix (ECM), that directs and organizes the deposition of inorganic minerals such as hydroxyapatite [3, 5]. In vertebrates, the most prominent biomineralization scaffold is the Type I collagen matrix found in bone and dentin, which provides the necessary spatial and chemical environment to control crystal nucleation, growth, and orientation [3, 6]. This scaffold is essential for the mechanical integrity of hard tissues and plays a critical role in skeletal development and repair [5]. Other proteins, such as ferritin and amelogenin, also function as specialized scaffolds for iron storage and enamel formation, respectively [2, 6]. While the term biomineralization scaffold describes a functional structural complex rather than a single molecular target, its components and the processes governing its formation are central to the treatment of metabolic bone diseases [1, 6]. Therapeutic strategies often focus on modulating the cells (osteoblasts and osteoclasts) that build or degrade this scaffold, or using synthetic biomimetic scaffolds in regenerative medicine to promote bone healing [3, 11]. For instance, bone morphogenetic proteins are used to induce the formation of the mineralized collagen scaffold in clinical settings [3, 5]. The development of advanced biomimetic scaffolds remains a key area of research for treating large segmental bone defects and other hard tissue injuries [5, 11].

Other names

Organic matrixMineralization templateExtracellular matrix of mineralized tissueMineralized collagen scaffold

Drugs interact with the biomineralization scaffold by either binding to the mineral-organic interface to inhibit resorption or by stimulating the cellular production of scaffold components like Type I collagen to promote new bone formation.